Phase III trial of gemcitabine (30 minute-infusion) versus gemcitabine (fixed dose rate infusion) versus gemcitabine + oxaliplatin (GEMOX) in patients with advanced pancreatic cancer. - Poplin,E. (Proc Am Soc Clin Oncol, 2006)